A61P 39 - General protective or antinoxious agents

Patents for A61P 39 - General protective or antinoxious agents (19,019)
12/2004
12/23/2004	US20040258813 Dehydrating; steaming; drying; freezing; pulverization
12/23/2004	US20040258692 Method for the treatment of cardiotoxicity induced by antitumor compounds
12/23/2004	US20040258634 Suitable for diabetics; gum diseases
12/23/2004	DE10324256A1 Lipid-Tranferprotein-Systeme und deren kosmetische/dermatologische Anwendung Lipid Tranferprotein systems and their cosmetic / dermatological use
12/22/2004	EP1489170A1 Transporter selectively transporting sulfate conjugate and its gene
12/22/2004	EP1488793A1 PREVENTIVES OR REMEDIES FOR DISEAES CAUSED BY eNOS EXPRESSION
12/22/2004	EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487448A1 Treatment of effect of chemicals with their ultradilute stereoisomers
12/22/2004	EP1487445A1 Obidoxime dimesylate
12/22/2004	EP1487431A1 Preventing and/or treating cardiovascular disease and/or associated heart failure
12/22/2004	EP1487404A1 Use of compatible solutes for inhibiting the release of ceramides
12/22/2004	EP1440067B1 N-formyl derivatives of paroxetine
12/22/2004	CN1180839C Powdery preparation containing polymeric medicine for mucosal administration
12/21/2004	US6833140 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
12/21/2004	US6833131 Antivenom immunesera
12/16/2004	WO2004108907A1 Nerve cell obtained by electrically pulse-treating es cell
12/16/2004	WO2003066666A3 Compositions and methods for treatment of vitamin d deficiency
12/16/2004	US20040254240 Anti-cancer nitro- and thia-fatty acids
12/16/2004	US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity
12/16/2004	US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
12/15/2004	EP1486210A1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
12/15/2004	EP1485085A1 Phosphate prodrugs of fluorooxindoles
12/15/2004	EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals
12/15/2004	EP1399033A4 Method for processing ginseng and processed ginseng obtained by the same
12/15/2004	CN1555487A A process for the isolation of a major harmful oxidant from cigarette smoke
12/15/2004	CN1555355A Substituted 4-aminocyclohexanol derivatives
12/15/2004	CN1555266A Hormone replacement therapy
12/15/2004	CN1555262A Novel 4,5-dihydro-1H-pyrazole derivatives having CB*-antagonistic activity
12/15/2004	CN1554356A Method for preparing baicalin liquid
12/14/2004	CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/09/2004	WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof
12/09/2004	WO2004105716A1 Lipidic protein-transfer systems and cosmetic/dermatological use thereof
12/09/2004	WO2004080429A3 Use of thiol-based compositions in ameliorating mucosal injury
12/09/2004	US20040248991 comprises ubiquinones; decreasing amount of urinary 8-hydroxydeoxyquanosine in diabetic animals
12/09/2004	US20040248944 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
12/09/2004	US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/09/2004	US20040248885 Use of thiazole derivatives for preparing a medicine for protecting mitochondria
12/09/2004	US20040248819 Administering fructose of fructose containing oligosaccharide
12/09/2004	US20040248771 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
12/09/2004	US20040247662 Systemic immune activation method using nucleic acid-lipid complexes
12/08/2004	EP1484400A1 Sodium-independent transporter carrying acidic amino acid and its gene
12/08/2004	EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004	EP1482962A2 Method of treating trx mediated diseases
12/08/2004	EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004	CN1553797A Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
12/08/2004	CN1552444A Amino acid containing human milk and superoxide dismutase composition and its preparation
12/08/2004	CN1552412A Prescription and use of salviae miltiorrhizae or lignum santali and salviae miltiorrhizae injection plus soluble intravenous infusion preparation
12/08/2004	CN1552407A Preparation of medicine against toxin in human body
12/08/2004	CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004	CN1178936C Sulfonyl-pyrrolidine derivatives
12/07/2004	US6828418 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
12/07/2004	US6828348 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same
12/07/2004	US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/07/2004	US6828306 Charged lipid compositions and methods for their use
12/07/2004	US6827951 Composition and method for smoke detoxification
12/02/2004	WO2004103988A1 Sulfur-containing proanthocyanidin oligomer composition and process for producing the same
12/02/2004	WO2004103392A1 Method of treatment of systemic injury secondary to burns
12/02/2004	WO2004084895A3 Modulation of cell death
12/02/2004	WO2003039452A3 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
12/02/2004	US20040242852 Bifunctional chelating agent for actinium
12/02/2004	US20040242701 Amines as ant-alcoholism agents
12/02/2004	US20040242651 to gastrointestal systems, kidneys
12/02/2004	US20040241803 25 human secreted proteins
12/02/2004	US20040238781 Using genistein; preadministering before exposure to radiation; prevent tissue damage
12/02/2004	CA2557625A1 Method of treatment of systemic injury secondary to burns
12/01/2004	EP1480973A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
12/01/2004	EP1173197B1 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
12/01/2004	CN1177844C Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
11/2004
11/30/2004	US6825229 Administering protein kinase c activators such as macrocyclic lactones (i.e. bryostatin class and neristatin class)
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/25/2004	WO2004071416B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/25/2004	US20040236116 Novel bicyclic and tricyclic cannabinoids
11/25/2004	US20040236101 Heteroindanes a new class of potent cannabimimetic ligands
11/25/2004	US20040235950 Administering, topically or systemically, an inhibitor of the matrix degrading enzymes and a cytokine inhibitor that alleviates inflammation and also alleviate neutrophil infiltration
11/25/2004	US20040235786 Highly purified antiendotoxin compound
11/25/2004	US20040235718 Use of Afamin, in particular in combination with vitamin E, is for treatment of oxidative stress; treatment of Alzheimer's Disease, Huntington's Disease or amyotropic lateral sclerosis
11/25/2004	US20040234950 Method for virus propagation
11/25/2004	US20040234674 Artichoke leaf extracts
11/24/2004	EP1479670A1 Novel fused ring indazole compounds
11/24/2004	EP1479392A1 Utilization of dietary supplements from plants, having properties against oxidative stress due to exercise in humans and animals
11/24/2004	EP1478731A1 Phenalenone derivatives, method for the production thereof and use of the same
11/24/2004	EP1478358A1 Aryl ureas with angiogenesis inhibiting activity
11/24/2004	EP1272201B1 Use of compatible solutes as substances having free radical scavenging properties
11/24/2004	EP1135519A4 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
11/24/2004	EP1024830B1 Antigen vectors in the form of multilamellar vesicles
11/24/2004	CN1549679A Foodstuff
11/24/2004	CN1176941C Caspase inhibitors and the use thereof
11/24/2004	CN1176602C Health food capable of increasing bone density and delaying senility and its production process
11/23/2004	US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004	CA2260835C Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
11/17/2004	EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476150A2 Carboxyfullerenes and methods of use thereof
11/17/2004	EP1257261B1 Antiviral pharmaceutical compositions containing iron chelators
11/17/2004	EP0679160B1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
11/17/2004	CN1547482A Use of POLY-GLU,TYR and T cells treated therewith for neuroprotective therapy
11/17/2004	CN1546087A Heart and brain nourishing products consisted of gadol mainly and its preparation
11/17/2004	CN1546041A Ursolic acid dripping pills and its preparation process

1 ... 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 ... 191